AbbVie ABBV expects to return to robust revenue growth in 2025, despite the U.S. loss of exclusivity (LOE) for its flagship ...

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the European Medicines Agency’s ...

Attackers are increasingly exploiting generative AI by embedding malicious prompts in macros and exposing hidden data through parsers. The switch in adversarial tactics — noted in a recent State of ...

This is a web edition of GBH Daily, a weekday newsletter bringing you local stories you can trust so you can stay informed without feeling overwhelmed. 🌂Cloudy with a slight chance of rain and highs ...

GLP-1 receptor agonists—the popular class of weight-loss drugs that include semaglutide (Ozempic)—may carry underrecognized risks for women of reproductive age, according to new research from ...

Jessica Simpson has shown off botched lip injections as she made her return to the 2025 VMAs after a nearly 20-year hiatus from the show. RadarOnline.com can reveal the singer was quickly slammed on ...

INJ price prediction points to $14.50 target within 4-6 weeks as Injective trades above key support at $13.04, though bearish MACD suggests caution near-term. Injective Protocol (INJ) presents a ...

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy.